fluconazole has been researched along with amoxicillin in 35 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 8 (22.86) | 29.6817 |
2010's | 25 (71.43) | 24.3611 |
2020's | 2 (5.71) | 2.80 |
Authors | Studies |
---|---|
Drummond, AJ; Khalaf, AI; McGroarty, I; Pringle, B; Skellern, GG; Suckling, CJ; Waigh, RD | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Bhattacharjee, G; Kumar, A; Tomar, V | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Abdel-Aziz, HA; Abdel-Wahab, BF; Ahmed, EM | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Fatahala, SS; Kamel, R; Mohamed, MS | 2 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
Al-Qawasmeh, RA; Al-Tel, TH; Zaarour, R | 1 |
Banerjee, S; Ghosh, S; Hazra, A; Maity, A; Mondal, NB; Mondal, S; Naskar, S; Paira, P; Paira, R; Saha, P; Sahu, KB; Samanta, A; Sinha, C | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Ishar, MP; Kaur, H; Saxena, AK; Sharma, V; Singh, G | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Bharathi, K; Haseena banu, B; Prasad, KV | 1 |
Kong, LY; Li, TX; Wang, XB; Wang, Y; Yang, MH | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Gao, F; Huang, G; Xiao, J | 1 |
Beteck, RM; Jesumoroti, OJ; Legoabe, LJ; Patel, OPS | 1 |
Aisse, L; Benamar, MY; Benjelloun, N; Kafih, M; Ridai, M; Rifki Jai, S; Zeroualli, ON | 1 |
Björnsson, E; Davidsdottir, L | 1 |
Bouabidi, A; Bouklouze, A; Boulanger, B; Bourichi, H; Brik, Y; El Karbane, M; Hubert, P; Rozet, E; Talbi, M | 1 |
Goff, TA; Kanakaris, NK | 1 |
Lai, NM; McDonald, SJ; Tan, K; Taylor, JE | 1 |
Hajjar, MA; Maatouk, I; Moutran, R | 1 |
Farman, M; Hameed, S; Jamal, MA; Khosa, MK; Muneer, M; Rehman, F; Saif, MJ; Shahid, M; Shoaib, HM | 1 |
Aldrovandi, GM; Cunningham, NJ; Kordy, K; Lee, DJ; Li, F; Romeo, AC; Saavedra, M; Tobin, N; Zabih, S | 1 |
Akroum, S | 1 |
4 review(s) available for fluconazole and amoxicillin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Current scenario of tetrazole hybrids for antibacterial activity.
Topics: Anti-Bacterial Agents; Bacteria; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Tetrazoles | 2019 |
Metronidazole-conjugates: A comprehensive review of recent developments towards synthesis and medicinal perspective.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Antiprotozoal Agents; Drug Development; Humans; Hypoglycemic Agents; Metronidazole | 2021 |
Antibiotic lock for the prevention of catheter-related infection in neonates.
Topics: Amoxicillin; Anti-Bacterial Agents; Catheter-Related Infections; Catheterization, Central Venous; Central Venous Catheters; Confidence Intervals; Fluconazole; Gentamicins; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Randomized Controlled Trials as Topic; Selection Bias; Vancomycin | 2015 |
31 other study(ies) available for fluconazole and amoxicillin
Article | Year |
---|---|
Distamycin analogues with enhanced lipophilicity: synthesis and antimicrobial activity.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Cell Line; Cricetinae; Distamycins; DNA; Electrophoresis, Capillary; Humans; Hydrophobic and Hydrophilic Interactions; Microbial Sensitivity Tests; Structure-Activity Relationship | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Synthesis and antimicrobial evaluation of new chalcones containing piperazine or 2,5-dichlorothiophene moiety.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Benzaldehydes; Candida; Candida albicans; Chalcones; Ciprofloxacin; Escherichia coli; Gram-Positive Bacteria; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Piperazines; Staphylococcus aureus; Structure-Activity Relationship; Thiophenes | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Synthesis and antimicrobial evaluation of 1-(benzofuran-2-yl)-4-nitro-3-arylbutan-1-ones and 3-(benzofuran-2-yl)-4,5-dihydro-5-aryl-1-[4-(aryl)-1,3-thiazol-2-yl]-1H-pyrazoles.
Topics: Anti-Bacterial Agents; Antifungal Agents; Aspergillus niger; Bacillus subtilis; Benzofurans; Candida albicans; Chalcones; Cyclization; Dose-Response Relationship, Drug; Drug Design; Escherichia coli; Microbial Sensitivity Tests; Molecular Structure; Pyrazoles; Staphylococcus aureus; Stereoisomerism; Structure-Activity Relationship; Thioamides | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Synthesis and biological evaluation of some thio containing pyrrolo [2,3-d]pyrimidine derivatives for their anti-inflammatory and anti-microbial activities.
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Bacteria; Fungi; Male; Microbial Sensitivity Tests; Pyrimidines; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Sulfur | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
Design, synthesis and in vitro antimicrobial evaluation of novel Imidazo[1,2-a]pyridine and imidazo[2,1-b][1,3]benzothiazole motifs.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Benzothiazoles; Dose-Response Relationship, Drug; Drug Design; Fungi; Imidazoles; Microbial Sensitivity Tests; Molecular Structure; Pyridines; Stereoisomerism; Structure-Activity Relationship | 2011 |
Amberlite-IRA-402 (OH) ion exchange resin mediated synthesis of indolizines, pyrrolo [1,2-a] quinolines and isoquinolines: antibacterial and antifungal evaluation of the products.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Fungi; Indolizines; Ion Exchange Resins; Isoquinolines; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Quinolines; Stereoisomerism; Structure-Activity Relationship | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
New condensed pyrroles of potential biological interest syntheses and structure-activity relationship studies.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Bacillus subtilis; Carrageenan; Edema; Hindlimb; Ibuprofen; Male; Microbial Sensitivity Tests; Pyrimidines; Pyrroles; Rats; Rats, Sprague-Dawley; Staphylococcus aureus; Structure-Activity Relationship | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Synthesis of β-ionone derived chalcones as potent antimicrobial agents.
Topics: Anti-Infective Agents; Bacteria; Bacterial Infections; Chalcones; Fungi; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mycoses; Norisoprenoids; Staphylococcal Infections | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Synthesis and biological evaluation of N-dehydrodipeptidyl-N,N'-dicyclohexylurea analogs.
Topics: Acetic Acid; Analgesics; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Bacteria; Carrageenan; Dose-Response Relationship, Drug; Edema; Fungi; Mice; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Pain; Rats; Structure-Activity Relationship; Urea | 2014 |
Synergistic Antifungal Meroterpenes and Dioxolanone Derivatives from the Endophytic Fungus Guignardia sp.
Topics: Antifungal Agents; Ascomycota; Biofilms; Candida albicans; Endophytes; Fluconazole; Microbial Sensitivity Tests; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Terpenes | 2015 |
[Colonic actinomycosis].
Topics: Abdominal Wall; Actinomycosis; Adult; Amoxicillin; Cecal Diseases; Colitis; Colonic Neoplasms; Colostomy; Combined Modality Therapy; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diarrhea; Female; Fluconazole; Gastritis; Gastrointestinal Hemorrhage; Granuloma; Humans; Ileostomy; Laparotomy; Middle Aged; Ultrasonography | 2004 |
The long-term follow-up after idiosyncratic drug-induced liver injury with jaundice.
Topics: Adult; Aged; Amiloride; Amoxicillin; Cause of Death; Female; Fluconazole; Fluoxetine; Follow-Up Studies; Halothane; Hepatitis, Autoimmune; Humans; Jaundice; Liver; Male; Middle Aged; Ranitidine; Time Factors | 2009 |
Flexibility and applicability of β-expectation tolerance interval approach to assess the fitness of purpose of pharmaceutical analytical methods.
Topics: Amoxicillin; Bias; Calibration; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Dosage Forms; Drug Contamination; Fluconazole; Limit of Detection; Linear Models; Metformin; Models, Statistical; Parabens; Pharmaceutical Preparations; Reference Standards; Reproducibility of Results; Spectrophotometry, Ultraviolet; Technology, Pharmaceutical | 2012 |
Management of infected non-union of the proximal femur: a combination of therapeutic techniques.
Topics: Adult; Amoxicillin; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Bone Cements; Candidiasis; Fluconazole; Fracture Fixation, Intramedullary; Fracture Healing; Fractures, Ununited; Hip Fractures; Humans; Male; Recovery of Function; Staphylococcal Infections; Treatment Outcome; Vancomycin; Wound Infection | 2014 |
Candida albicans and Streptococcus pyogenes balanitis: diabetes or STI?
Topics: Amoxicillin; Anti-Bacterial Agents; Antifungal Agents; Balanitis; Candida albicans; Candidiasis; Diabetes Mellitus; Fluconazole; Humans; Male; Middle Aged; Sexually Transmitted Diseases; Streptococcal Infections; Streptococcus pyogenes; Treatment Outcome | 2015 |
Synthesis, Spectral investigation (¹H, ¹³C) and Anti-microbial Screening of benzophenone imines.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Bacteria; Benzophenones; Carbon-13 Magnetic Resonance Spectroscopy; Disk Diffusion Antimicrobial Tests; Fluconazole; Fungi; Imines; Proton Magnetic Resonance Spectroscopy; Spectroscopy, Fourier Transform Infrared; Transition Temperature | 2015 |
Combination Antibiotics Improves Disease Activity and Alters Microbial Communities in Children With Ulcerative Colitis.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Child; Colitis, Ulcerative; Doxycycline; Female; Fluconazole; Gastrointestinal Microbiome; Humans; Male; Metronidazole; Retrospective Studies; Vancomycin; Young Adult | 2018 |
[Anti-microbial activity of Rosmarinus officinalis and Zingiber officinale extracts on the species of the genus Candida and on Streptococcus pneumonia].
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Antifungal Agents; Candida; Candidiasis; Ethanol; Fluconazole; Ledum; Male; Methanol; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Plant Extracts; Rats; Rats, Wistar; Solvents; Streptococcal Infections; Streptococcus pneumoniae; Zingiber officinale | 2021 |